Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009 - Results from the IBD Cohort of the Uppsala Region (ICURE)

Journal of Crohn's and Colitis

Volumn 7, Issue 9, 2013, Pages

  Sjöberg, Daniel ^a   Holmström, Tommy ^b   Larsson, Märit ^c   Nielsen, Anne Lie ^c   Holmquist, Lars ^d   Ekbom, Anders ^e   Rönnblom, Anders ^d  

^a FALUN HOSPITAL   (Sweden)

^b Department of Internal Medicine ^*  (Finland)

^c Mälar Hospital Eskilstuna   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Epidemiology; Incidence; Inflammatory bowel diseases; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ASSESSMENT; COLON RESECTION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; SCHOOL CHILD; SMOKING; SWEDEN; ULCERATIVE COLITIS;

EPIDEMIOLOGY; INCIDENCE; INFLAMMATORY BOWEL DISEASES; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; RECURRENCE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; STEROIDS; SWEDEN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84881546979     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.02.006     Document Type: Article

References (39)

1. Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 2004, 18(3):463-479.
2. Lakatos P. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J Gastroenterol 2006, 12(38):6102-6108.
3. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126(6):1504-1517.
4. Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., et al. Increasing Incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142(1):46-54.
5. Ronnblom A., Samuelsson S.M., Ekbom A. Ulcerative colitis in the county of Uppsala 1945-2007: incidence and clinical characteristics. J Crohns Colitis 2010, 4(5):532-536.
6. Ekbom A., Helmick C., Zack M., Adami H.O. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991, 100(2):350-358.
7. Tysk C., Jarnerot G. Ulcerative proctocolitis in Orebro, Sweden. A retrospective epidemiologic study, 1963-1987. Scand J Gastroenterol 1992, 27(11):945-950.
8. Statistics Sweden, tables on the population in Sweden 2009 2009.
9. Sands B.E. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004, 126(6):1518-1532.
10. Satsangi J., Silverberg M.S., Vermeire S., Colombel J.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006, 55(6):749-753.
11. Jussila A., Virta L.J., Kautiainen H., Rekiaro M., Nieminen U., Farkkila M.A. Increasing incidence of inflammatory bowel diseases between 2000 and 2007: a nationwide register study in Finland. Inflamm Bowel Dis 2012, 18(3):555-561.
12. Shivananda S., Lennard-Jones J., Logan R., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996, 39(5):690-697.
13. Chouraki V., Savoye G., Dauchet L., et al. The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther 2011, 33(10):1133-1142.
14. Loftus C.G., Loftus E.V., Harmsen W.S., et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007, 13(3):254-261.
15. Moum B., Vatn M.H., Ekbom A., et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996, 31(4):362-366.
16. Lindberg E., Lindquist B., Holmquist L., et al. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J Pediatr Gastroenterol Nutr 2000, 30(3):259-264.
17. Hildebrand H., Finkel Y., Grahnquist L., et al. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut 2003, 52(10):1432-1434.
18. Idestrom M. Pathophysiological and clinical studies on Crohn's disease in children. Thesis published by Karolinska Institutet 2012. ISBN 978-91-7457-701-3.
19. Reif S., Klein I., Lubin F., et al. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997, 40:754-760.
20. Geerling B.J., Dagnelie P.C., Badart-Smook A., et al. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000, 95:1008-1013.
21. Sakamoto N., Kono S., Wakai K., et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005, 11:154-163.
22. IBD in EPIC Study Investigators, Tjonneland A., Overvad K., Bergmann M.M., et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009, 58:1606-1611.
23. Freisling H., Fahey M.T., Moskal A., et al. Region-specific nutrient intake patterns exhibit a geographical gradient within and between European countries. J Nutr 2010, 140(7):1280-1286.
24. Becker W., Haglund M., Wretling S. Fett och fettsyror i den svenska kosten 2008, National Food Administration, Sweden. 1104-7089.
25. Harries A.D., Baird A., Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982, 284(6317):706.
26. OECD Health at a glance 2009, OECD Publishing.
27. Vind I., Riis L., Jess T., Knudsen E., Pedersen N., Elkjaer M., et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006, 101(6):1274-1282.
28. Lakatos L., Kiss L.S., David G., Pandur T., Erdelyi Z., Mester G., et al. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 2011, 17(12):2558-2565.
29. Gower-Rousseau C., Dauchet L., Vernier-Massouille G., Tilloy E., Brazier F., Merle V., et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol 2009, 104(8):2080-2088.
30. Edwards F.C., Truelove S.C. The course and prognosis of ulcerative colitis. Gut 1963, 4:299-315.
31. Solberg I.C., Lygren I., Jahnsen J., Aadland E., Hoie O., Cvancarova M., et al. Clinical course during the first 10years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009, 44(4):431-440.
32. Moum B., Ekbom A., Vatn M.H., Aadland E., Sauar J., Lygren I., et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol 1997, 32(10):1005-1012.
33. Hoie O., Schouten L.J., Wolters F.L., Solberg I.C., Riis L., Mouzas I.A., et al. Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10years after diagnosis. Gut 2007, 56(4):497-503.
34. Jess T., Gamborg M., Munkholm P., Sorensen T.I. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007, 102(3):609-617.
35. Bjornsson S., Johannsson J.H. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000, 12(1):31-38.
36. Bernstein C.N., Wajda A., Svenson L.W., MacKenzie A., Koehoorn M., Jackson M., et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006, 101(7):1559-1568.
37. Wilson J., Hair C., Knight R., Catto-Smith A., Bell S., Kamm M., et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis 2010, 16(9):1550-1556.
38. Ott C., Obermeier F., Thieler S., Kemptner D., Bauer A., Scholmerich J., et al. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol 2008, 20(9):917-923.
39. Yang S., Yun S., Kim J., Park J.Y., Kim H.Y., Kim Y.H., et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008, 14(4):542-549.